Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of the Rheumatic Diseases
Authors: Naomi Schlesinger, Eduardo Mysler, Hsiao-Yi Lin, Marc De Meulemeester, Jozef Rovensky, Udayasankar Arulmani, Alison Balfour, Gerhard Krammer, Peter Sallstig, Alexander So
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Novartis Pharma
OpenAlex ID: W2137091038
